Triple-negative (TNBC) and human epidermal growth factor receptor-2 (HER2)-positive breast cancers display higher prevalence of stromal tumor-infiltrating lymphocytes (sTILs) than estrogen receptor (ER)-positive breast cancers1–3. Here, ERBB2 is linked to neoplasm.